Last updated: 22 July 2019 at 11:55pm EST

Jon E M Jacoby Net Worth




The estimated Net Worth of Jon E M Jacoby is at least $117 millió dollars as of 7 January 2014. Jon Jacoby owns over 10,000 units of Sangamo Therapeutics Inc stock worth over $399,244 and over the last 21 years Jon sold SGMO stock worth over $116,399,631.

Jon Jacoby SGMO stock SEC Form 4 insiders trading

Jon has made over 11 trades of the Sangamo Therapeutics Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently Jon sold 10,000 units of SGMO stock worth $745,000 on 7 January 2014.

The largest trade Jon's ever made was selling 2,278,426 units of Sangamo Therapeutics Inc stock on 7 December 2012 worth over $57,894,805. On average, Jon trades about 102,901 units every 103 days since 2003. As of 7 January 2014 Jon still owns at least 475,291 units of Sangamo Therapeutics Inc stock.

You can see the complete history of Jon Jacoby stock trades at the bottom of the page.



What's Jon Jacoby's mailing address?

Jon's mailing address filed with the SEC is Stephens Building, 111, Center Street, Little Rock, Pulaski County, Arkansas, 72201, United States.

Insiders trading at Sangamo Therapeutics Inc

Over the last 24 years, insiders at Sangamo Therapeutics Inc have traded over $87,969,621 worth of Sangamo Therapeutics Inc stock and bought 3,434,008 units worth $48,483,268 . The most active insiders traders include Capital Management, L.P.Ra ..., Le Roy C Kopp és Inc.Biogen Ma Inc. Biogen. On average, Sangamo Therapeutics Inc executives and independent directors trade stock every 21 days with the average trade being worth of $40,671. The most recent stock trade was executed by Inc.Biogen Ma Inc. Biogen on 26 September 2023, trading 6,000,000 units of SGMO stock currently worth $3,000,000.



What does Sangamo Therapeutics Inc do?

for sangamo therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. to learn more about sangamo, visit the our website at www.sangamo.com.



Complete history of Jon Jacoby stock trades at Conns Inc és Sangamo Therapeutics Inc

Az érdekelt
Trans.
Tranzakció
Teljes ár
Jon E M Jacoby
Rendező
Eladás $745,000
7 Jan 2014
Jon E M Jacoby
Rendező
Eladás $51,610,000
12 Jun 2013
Jon E M Jacoby
Rendező
Eladás $310,770
26 Apr 2013
Jon E M Jacoby
Rendező
Eladás $836,600
16 Apr 2013
Jon E M Jacoby
Rendező
Eladás $4,168,457
9 Apr 2013
Jon E M Jacoby
Rendező
Eladás $834,000
23 Jan 2013
Jon E M Jacoby
Rendező
Opció Gyakorlat $906,500
27 Dec 2012
Jon E M Jacoby
Rendező
Opció Gyakorlat $906,500
27 Dec 2012
Jon E M Jacoby
Rendező
Eladás $57,894,805
7 Dec 2012
Jon E M Jacoby
Rendező
Opció Gyakorlat $166,744
29 May 2012
Jon E M Jacoby
Rendező
Megvenni $72,030
11 Feb 2004


Sangamo Therapeutics Inc executives and stock owners

Sangamo Therapeutics Inc executives and other stock owners filed with the SEC include: